FC09794 |
32222-06-3 |
1a,25-Dihydroxyvitamin D3 |
|
Agonist of calcitriol receptor; vitamin D3 analog; controls calcium homeostasis |
|
FM162210 |
213250-70-5 |
2MD |
|
Agonist of vitamin D receptor in bone |
|
FR11993 |
08.03.5300 |
9-cis-Retinoic acid |
|
Ligand of retinoid X receptor RXRα |
|
BA164136 |
55079-83-9 |
Acitretin- Bio-X |
|
Retinoid;activates nuclear retinoid acid receptor; antineoplastic; anti-psoratic |
|
BA164138 |
106685-40-9 |
Adapalene- Bio-X |
|
Agonist of retinoic acid receptors (RAR-β and RAR-γ); pro-apoptotic |
|
FD17242 |
171746-21-7 |
AGN 193109 |
|
Pan-retinoic acid receptor (RAR) antagonist |
|
FA137469 |
102121-60-8 |
AM 580 |
|
Retinoic acid receptor (RARα) agonist; induces cell differentiation |
|
FA64943 |
956104-40-8 |
ARN 509 |
|
Androgen receptor antagonist; prostate cancer treatment |
|
FA103981 |
1240299-33-5 |
AZD 3514 |
|
Androgen receptor antagonist; has therapeutic application in prostate cancer |
|
FA162614 |
1639042-08-2 |
AZD 9496 |
|
Estrogen receptor (ER) antagonist |
|
BZ162710 |
42422-68-4 |
Beta-Zearalanol |
|
Estrogen receptor agonist |
|
BZ162711 |
71030-11-0 |
Beta-Zearalenol |
|
Estrogen receptor agonist; macrolide |
|
BB164246 |
153559-49-0 |
Bexarotene- Bio-X |
|
Agonist of retinoid X receptor; neuroprotective |
|
BB166159 |
41859-67-0 |
Bezafibrate |
|
Peroxisome proliferator-activated receptor agonist; hypolipidemic drug |
|
BB166739 |
627530-84-1 |
BMS 564929 |
|
Androgen receptor modulator |
|
FB167336 |
573738-99-5 |
BMS 641988 |
|
Androgen receptor (AR) antagonist |
|
BB164267 |
51333-22-3 |
Budesonide |
|
Glucocorticoid receptor agonist; anti-inflammatory |
BIO-R |
FC166171 |
976-71-6 |
Canrenone |
|
Mineralocorticoid (aldosterone) receptor antagonist |
BIO-R |
BC170775 |
1178240-51-1 |
CCG 58150 |
|
Rho/MRTF/SRF mediated gene transcription inhibitor |
|
FC19935 |
302-22-7 |
Chlormadinone acetate |
|
Progesterone receptor agonist; androgen receptor antagonist; oral contraceptive |
|
FC20428 |
126544-47-6 |
Ciclesonide |
|
Glucocorticoid; anti-inflammatory; anti-asthmatic agent |
|
BD164311 |
52214-84-3 |
Ciprofibrate- Bio-X |
|
Agonist of peroxisome proliferator-activated receptor PPARα ; hypolipidemic |
|
FC20501 |
50-41-9 |
Clomiphene citrate (cis-trans mixture) |
|
Estrogen receptor modulator; used to treat infertility |
|
FD64992 |
1110813-31-4 |
Dacomitinib |
|
Pan-EGFR inhibitor (HER1, HER2 and HER4); antineoplastic |
|
FD161413 |
1297538-32-9 |
Darolutamide |
|
Androgen receptor antagonist; therapy for endometriosis |
|
BD162804 |
1361504-77-9 |
DG 172 hydrochloride |
|
Agonist of peroxisome proliferator-activated receptors PPARβ/δ |
|
FB66440 |
1428-67-7 |
DPN |
|
Estrogen ERβ receptor agonist; regulates GluR1, GluR2 and GluR3 expression |
|
BD166530 |
67392-87-4 |
Drospirenone- Bio-X |
|
Progestogen; anti-androgen; anti-mineralocorticoid |
|
FE177759 |
1349723-93-8 |
Elacestrant dihydrochloride |
|
|
|
BE163306 |
923978-27-2 |
Elafibranor |
|
Dual agonist of PPARα and PPARδ receptors |
|
FC65076 |
915087-33-1 |
Enzalutamide |
|
Androgen receptor antagonist |
|
BE164415 |
107724-20-9 |
Eplerenone- Bio-X |
|
Aldosterone blocker |
|
FE23206 |
54350-48-0 |
Etretinate |
|
Used to treat psoriasis; teratogenic |
|
FF23268 |
65646-68-6 |
Fenretinide |
|
Modulator of RBP protein; activator of sphingomyelinase; pro-apoptotic |
|
FF15770 |
67-73-2 |
Fluocinolone acetonide |
|
Corticosteroid; anti-inflammatory; treats dermatological conditions |
|
BF176452 |
67-73-2 |
Fluocinolone acetonide - BP |
|
|
|
BF166239 |
13311-84-7 |
Flutamide |
|
Non-steroidal androgen receptor antagonist |
BIO-R |
BF161262 |
80474-14-2 |
Fluticasone propionate- Bio-X |
|
Glucocorticoid receptor agonist; anti-inflammatory |
|
BF160362 |
80474-14-2 |
Fluticasone propionate - micronised pharma grade |
|
Glucocorticoid receptor agonist; anti-inflammatory |
|
BF168364 |
329932-55-0 |
FM 19G11 NEW |
|
Inhibitor of HIF1α transcription factor |
|
FT65187 |
851983-85-2 |
Galeterone |
|
CYP17 lyase inhibitor; androgen receptor antagonist |
|
FG137678 |
1365888-06-7 |
GDC 0810 |
|
Estrogen receptor degrader; therapeutic use in breast cancer |
|
BG166429 |
1642297-01-5 |
GDC 0927 |
|
Degrader of estrogen receptor |
|
BG164505 |
60282-87-3 |
Gestodene- Bio-X |
|
Synthetic progestin; contraceptive |
|
FG167327 |
101574-65-6 |
GSK 4716 |
|
Agonist of estrogen-related receptors ERRβ and ERRγ |
|
FG137681 |
1346572-63-1 |
GSK 503 |
|
Inhibits EZH2 methyltransferase; antineoplastic |
|
FG23723 |
317318-84-6 |
GW 0742 |
|
Peroxisome proliferator-activated receptor PPARβ/δ agonist |
|
FG23720 |
278779-30-9 |
GW 4064 |
|
Farnesoid X receptor agonist |
|
FM23721 |
317318-70-0 |
GW 501516 |
|
PPAR β/δ agonist; modulates lipid catabolism; anti-obesity agent |
|
FC20132 |
22978-25-2 |
GW 9662 |
|
PPARγ antagonist |
|